News
Climate change raises fungal pathogen pressure
Warming, extreme weather and transport are changing fungal-disease risk in people, animals and plants. The authors of this three-page Comment set surveillance priorities; it is not a systematic review.
Pathogenic fungi respond to climate, but not according to a simple equation in which warmer means more infections. A comment published in Nature Reviews Microbiology sets out the evidence that variability in temperature, droughts, floods and the movement of organisms can open new routes for pathogens. This applies to diseases of humans, animals and plants. The text does not describe a single experiment; it is a synthetic expert view and a proposal of priorities for research and public health.
Temperature is an important barrier for many environmental fungi. The warm body of a mammal limits the number of species able to grow in tissue, yet populations under thermal pressure may adapt. Climate change simultaneously affects hosts: heat stress, malnutrition, damage after extreme weather and changes in immunity may increase susceptibility. A single case of infection cannot therefore be attributed to global mean temperature alone.
A pathogen's range also depends on the transport of spores, animals and goods. Dust storms can carry particles over long distances, and trade in plants and agricultural produce bypasses natural geographical barriers. When an organism reaches a new place, local weather decides whether it finds a period favourable to growth. The authors therefore stress the need to combine meteorological data with clinical, veterinary and phytosanitary diagnostics.
The largest gap is organisational. Fungal infections are often detected late, laboratories do not everywhere identify to species level, and drug resistance is monitored unevenly. Better surveillance makes sense only when a result leads to action: faster treatment, control of an outbreak, a change in agricultural practice or a warning to at-risk groups. New drugs, tests, sensible use of existing preparations and vaccine research are also needed.
This is not a reason to fear fungi in the forest. Most species do not infect people, and warming alone does not turn a saprotroph into a pathogen. It is an argument for systematic preparation for rare but costly events. Forecasts should state their uncertainty and distinguish possibility from an observed trend. The most important message is practical: climate, health and mycology cannot be monitored in separate silos when the same organism crosses the boundaries of sectors and states.
The good news is that much of what is needed does not require waiting for a perfect model. Standard reporting, banking isolates, sequencing outbreaks and training laboratories improve the response regardless of which climate scenario turns out to be closest to reality. Surveillance should at the same time protect patient privacy and share the aggregated data needed for warnings. That is work measured in years.
Source status — 29 August 2026
The piece was published on 14 July 2026 as a three-page Comment in Nature Reviews Microbiology. It is neither a systematic review nor a new experiment: the authors synthesize established examples and set priorities for surveillance, diagnostics, forecasting and health policy. It therefore supports the direction of risk, but supplies no single global increase in infections and cannot attribute an individual case to climate change. Its value is in joining climate, clinical, veterinary and plant-health data into one programme of action, while requiring uncertainty to be reported explicitly.
How to read the scope of the Comment
The Comment joins three scales that should not be collapsed into one forecast. The first is fungal physiology: thermal tolerance can shift a growth barrier. The second is host susceptibility altered by heat, injury or malnutrition. The third covers transport, diagnostics and surveillance quality, which determine whether an organism's arrival is detected at all.
- Supported direction: climate can change conditions of exposure and selection.
- No single number: the publication does not calculate a global rise in infections.
- Operational conclusion: clinical series need to be linked with weather, location, species identification and resistance.
This is a framework for designing surveillance, not a risk calculator for an individual person or a walk in the woods.
Written by MykoRadar from the source indicated. Informational only — it does not replace advice from an expert.